4//SEC Filing
Nark Ted C 4
Accession 0001209191-23-028731
CIK 0001723128other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:15 PM ET
Size
11.2 KB
Accession
0001209191-23-028731
Insider Transaction Report
Form 4
Nark Ted C
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2023-05-10+80,128→ 224,318 total - Award
Restricted Stock Units
2023-05-09+76,453→ 76,453 total→ Class A Common Stock (76,453 underlying) - Exercise/Conversion
Restricted Stock Units
2023-05-10−80,128→ 0 total→ Class A Common Stock (80,128 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
- [F3]On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001316851
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:15 PM ET
- Size
- 11.2 KB